Rare-disease researchers pioneer a unique approach to clinical trials

Randomization and placebo groups are giving way to biomarkers, real-world data from wearables, and multi-center and adaptive trials.

Automated summary

Randomization and placebo groups are being replaced by biomarkers, real-world data from wearables, and multi-center and adaptive trials.